Fujimoto H - Search Results

1

Indication of splenectomy for gastric carcinoma involving the proximal part of the stomach.

Sakaguchi T, Sawada H, Yamada Y, Fujimoto H, Emoto K, Takayama T, Ueno M, Nakajima Y. Sakaguchi T, et al. Among authors: fujimoto h. Hepatogastroenterology. 2001 Mar-Apr;48(38):603-5. Hepatogastroenterology. 2001. PMID: 11379363

2

Characteristics and clinical outcome of proximal-third gastric cancer.

Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Tatsumi M, Fujimoto H, Emoto K, Nakano H. Sakaguchi T, et al. Among authors: fujimoto h. J Am Coll Surg. 1998 Oct;187(4):352-7. doi: 10.1016/s1072-7515(98)00191-4. J Am Coll Surg. 1998. PMID: 9783780

3

Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma.

Emoto K, Sawada H, Yamada Y, Fujimoto H, Takahama Y, Ueno M, Takayama T, Uchida H, Kamada K, Naito A, Hirao S, Nakajima Y. Emoto K, et al. Among authors: fujimoto h. Anticancer Res. 2001 Mar-Apr;21(2B):1339-45. Anticancer Res. 2001. PMID: 11396210

4

The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.

Takahama Y, Yamada Y, Emoto K, Fujimoto H, Takayama T, Ueno M, Uchida H, Hirao S, Mizuno T, Nakajima Y. Takahama Y, et al. Among authors: fujimoto h. Gastric Cancer. 2002;5(2):61-8. doi: 10.1007/s101200200011. Gastric Cancer. 2002. PMID: 12111580

5

Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis.

Kamada K, Yamada Y, Hirao T, Fujimoto H, Takahama Y, Ueno M, Takayama T, Naito A, Hirao S, Nakajima Y. Kamada K, et al. Among authors: fujimoto h. Oncol Rep. 2004 Sep;12(3):593-9. Oncol Rep. 2004. PMID: 15289843

6

Antisense epidermal growth factor receptor delivered by adenoviral vector blocks tumor growth in human gastric cancer.

Hirao T, Sawada H, Koyama F, Watanabe A, Yamada Y, Sakaguchi T, Tatsumi M, Fujimoto H, Emoto K, Narikiyo M, Oridate N, Nakano H. Hirao T, et al. Among authors: fujimoto h. Cancer Gene Ther. 1999 Sep-Oct;6(5):423-7. doi: 10.1038/sj.cgt.7700058. Cancer Gene Ther. 1999. PMID: 10505852

7

Bcl-X expression in esophageal squamous cell carcinoma: association with tumor progression and prognosis.

Takayama T, Nagao M, Sawada H, Yamada Y, Emoto K, Fujimoto H, Ueno M, Hirao S, Nakajima Y. Takayama T, et al. Among authors: fujimoto h. J Surg Oncol. 2001 Oct;78(2):116-23. doi: 10.1002/jso.1130. J Surg Oncol. 2001. PMID: 11579389

8

Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma.

Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S, Nakajima Y. Emoto K, et al. Among authors: fujimoto h. Cancer. 2001 Sep 15;92(6):1419-26. doi: 10.1002/1097-0142(20010915)92:6<1419::aid-cncr1465>3.0.co;2-j. Cancer. 2001. PMID: 11745218

9

Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas.

Hirao S, Yamada Y, Koyama F, Fujimoto H, Takahama Y, Ueno M, Kamada K, Mizuno T, Maemondo M, Nukiwa T, Matsumoto K, Nakamura T, Nakajima Y. Hirao S, et al. Among authors: fujimoto h. Cancer Gene Ther. 2002 Aug;9(8):700-7. doi: 10.1038/sj.cgt.7700482. Cancer Gene Ther. 2002. PMID: 12136432

10

Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene.

Ueno M, Koyama F, Yamada Y, Fujimoto H, Takayama T, Kamada K, Naito A, Hirao S, Mukogawa T, Hamada H, Nakajima Y. Ueno M, et al. Among authors: fujimoto h. Anticancer Res. 2001 Jul-Aug;21(4A):2601-8. Anticancer Res. 2001. PMID: 11724328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,069 results

Search Page

Filters